Orthocell Ltd has released a press release.
Remplir Gains Australian Reimbursement
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Orthocell
- OrthoATI Rotator Cuff Study Success With Cross-Over Patients
- First orders for Striate and Remplir
- Appointment of Exclusive Australian Distributor for Remplir
- Final Report and Annual Report to Shareholders
- Striate Global License and Distribution Agreement Update
Later from Orthocell
- Appendix 4C - Quarterly
- Half Yearly Report and Accounts
- Leading US-based nerve surgeons appointed to advisory board
- Orthocell commences nerve repair study
- Orthocell receives A$3.17m R&D tax incentive refund
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell